Revance Therapeutics, Inc. Gains 21.58%
Thu, Sep 08, 2022 at 07:25 PM
Revance Therapeutics, Inc. (RVNC:NASDAQ) soared at $25.3, representing a gain of 21.6%. On Thu, Sep 08, 2022, RVNC:NASDAQ touched a New 2-Week High of $25.3. The stock appeared on our News Catalysts scanner on Thu, Sep 08, 2022 at 11:43 AM in the 'BIOTECH' category. From Thu, Aug 25, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days
About Revance Therapeutics, Inc. (RVNC:NASDAQ)
Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 176.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 51.01%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 48.58%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 33.02%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 31.5%
- Palatin Technologies, Inc. (PTN:NYSEMKT), 26.2%
- LifeStance Health Group Inc. (LFST:NASDAQ), 25.76%
- Asana Inc. Class A (ASAN:NYSE), 24.79%
- Relay Therapeutics Inc. (RLAY:NASDAQ), 23.75%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 21.58%